๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of Somatization Disorder with Nefazodone: A Prospective, Open-Label Study

โœ Scribed by Matthew Menza; Marc Lauritano; Lesley Allen; Melissa Warman; Frank Ostella; Robert M. Hamer; Javier Escobar

Book ID
110310273
Publisher
American Academy of Clinical Psychiatrists
Year
2001
Tongue
English
Weight
54 KB
Volume
13
Category
Article
ISSN
1040-1237

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pilot open-label study of nefazodone in
Pilot open-label study of nefazodone in panic disorder
โœ Alexander Bystritsky; Richard Rosen; Rita Suri; Tanya Vapnik ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 56 KB ๐Ÿ‘ 2 views

Ten patients meeting DSM-IV criteria for non-comorbid panic disorder or panic disorder with agoraphobia were treated in a 12-week open-label, flexible dosage trial of nefazodone. Dosages ranged from 50 to 400 mg per day. Clinical assessment utilized several recently developed scales of panic disorde